160 related articles for article (PubMed ID: 33887393)
1. The in vitro and in vivo study of novel formulation of andrographolide PLGA nanoparticle embedded into gelatin-based hydrogel to prolong delivery and extend residence time in joint.
Kulsirirat T; Sathirakul K; Kamei N; Takeda-Morishita M
Int J Pharm; 2021 Jun; 602():120618. PubMed ID: 33887393
[TBL] [Abstract][Full Text] [Related]
2. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W
Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858
[TBL] [Abstract][Full Text] [Related]
3. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
4. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y
Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642
[TBL] [Abstract][Full Text] [Related]
5. Oral delivery of topotecan in polymeric nanoparticles: Lymphatic distribution and pharmacokinetics.
Jeong SH; Jang JH; Lee YB
J Control Release; 2021 Jul; 335():86-102. PubMed ID: 34015399
[TBL] [Abstract][Full Text] [Related]
6. Formulation of stabilizer-free, nontoxic PLGA and elastin-PLGA nanoparticle delivery systems.
Stromberg ZR; Lisa Phipps M; Magurudeniya HD; Pedersen CA; Rajale T; Sheehan CJ; Courtney SJ; Bradfute SB; Hraber P; Rush MN; Kubicek-Sutherland JZ; Martinez JS
Int J Pharm; 2021 Mar; 597():120340. PubMed ID: 33545284
[TBL] [Abstract][Full Text] [Related]
7. PLGA/Ag nanocomposites: in vitro degradation study and silver ion release.
Fortunati E; Latterini L; Rinaldi S; Kenny JM; Armentano I
J Mater Sci Mater Med; 2011 Dec; 22(12):2735-44. PubMed ID: 22002470
[TBL] [Abstract][Full Text] [Related]
8. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
Wang N; Wu XS; Li JK
Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
[TBL] [Abstract][Full Text] [Related]
9. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
Mehta AK; Yadav KS; Sawant KK
Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
Mistry NP; Desai JL; Thakkar HP
J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
[TBL] [Abstract][Full Text] [Related]
11. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
12. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
14. Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers.
Choonara YE; Pillay V; Ndesendo VM; du Toit LC; Kumar P; Khan RA; Murphy CS; Jarvis DL
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):243-54. PubMed ID: 21664111
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of polylactic-co-glycolic acid/insulin nanoparticles encapsulated in methacrylate coated gelatin with sustained release for specific medical applications.
Akhavan Farid E; Davachi SM; Pezeshki-Modaress M; Taranejoo S; Seyfi J; Hejazi I; Tabatabaei Hakim M; Najafi F; D'Amico C; Abbaspourrad A
J Biomater Sci Polym Ed; 2020 May; 31(7):910-937. PubMed ID: 32009574
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of oxaceprol-loaded poly-lactide-co-glycolide nanoparticles for the treatment of osteoarthritis.
Alarçin E; Demirbağ Ç; Karsli-Ceppioglu S; Kerimoğlu O; Bal-Ozturk A
Drug Dev Res; 2020 Jun; 81(4):501-510. PubMed ID: 31958153
[TBL] [Abstract][Full Text] [Related]
17. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
Li X; Xu Y; Chen G; Wei P; Ping Q
Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
[TBL] [Abstract][Full Text] [Related]
18. Development of 6-Thioguanine conjugated PLGA nanoparticles through thioester bond formation: Benefits of electrospray mediated drug encapsulation and sustained release in cancer therapeutic applications.
Chatterjee M; Jaiswal N; Hens A; Mahata N; Chanda N
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111029. PubMed ID: 32994006
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of surgical tumor resection with implantation of a hydrogel containing camptothecin-loaded poly(lactic-co-glycolic acid) microspheres in a C6 rat glioma model.
Ozeki T; Kaneko D; Hashizawa K; Imai Y; Tagami T; Okada H
Biol Pharm Bull; 2012; 35(4):545-50. PubMed ID: 22466559
[TBL] [Abstract][Full Text] [Related]
20. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID
Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]